Dianthus Therapeutics (DNTH) Change in Cash (2017 - 2025)

Dianthus Therapeutics' Change in Cash history runs 9 years deep, the most recent figure standing at $42.7 million for Q3 2025.

• In Q3 2025, Change in Cash rose 115.23% year-over-year to $42.7 million; the TTM figure through Sep 2025 stood at $22.3 million (up 118.02% YoY), while the FY2024 annual figure was -$109.4 million, down 193.5% from the prior year.
• Change in Cash for Q3 2025 stood at $42.7 million, up from $3.1 million in the prior quarter.
• The five-year high for Change in Cash was $197.4 million in Q1 2024, with the low at -$280.3 million in Q3 2024.
• The 5-year median for Change in Cash is -$8.9 million (2021), against an average of $6.4 million.
• Peak annual rise in Change in Cash reached 4136.37% in 2022, while the deepest fall reached 575.67% in 2022.
• Dianthus Therapeutics' Change in Cash stood at -$25.9 million in 2021, then grew by 16.89% to -$21.5 million in 2022, then decreased by 15.99% to -$25.0 million in 2023, then jumped by 56.41% to -$10.9 million in 2024, then jumped by 492.38% to $42.7 million in 2025.
• Business Quant data shows DNTH's Change in Cash at $42.7 million in Q3 2025, $3.1 million in Q2 2025, and -$12.7 million in Q1 2025.